Sea buckthorn and circulating stem cells: what a 2019 study actually found
A 2019 human study gave participants a sea buckthorn berry extract and measured circulating stem cell markers over two hours. The extract group showed a rapid rise in those markers versus a flat placebo line, a preliminary but specific finding worth understanding precisely.
This article reports and cites one published human study. It does not claim that sea buckthorn puree, or any Human Renaissance product, produces this effect; the study used an isolated extract, not a whole-food puree.
The short answer
In a 2019 human study, researchers gave one group of participants a sea buckthorn berry phytochemical extract, called SBB-PE, and a placebo to another group, then drew blood at baseline, one hour and two hours. The SBB-PE group showed a rapid, selective increase in two circulating stem-like cell markers, CD45-/CD90+ and CD45dim/CD90+, that rose above baseline by the two-hour mark, while the placebo group's levels stayed flat or dipped slightly below baseline. The two-hour difference was reported as a statistical trend, not a fully significant result, in one small study that has not been widely replicated.
In this article
What circulating stem cells are, in plain terms
Before looking at the study, it helps to be clear about what was actually being counted, because the phrase "stem cells" carries a lot of assumptions that this research does not support.
Stem cells are the body's unspecialised repair cells. Unlike a skin cell or a muscle cell, which already has a fixed job, a stem cell can renew itself and, under the right signals, mature into other cell types. Most of them sit quietly inside tissue such as bone marrow. A smaller number circulate in the bloodstream at any given moment, and it is that circulating fraction, not the whole reserve, that the 2019 study looked at. If you want the full plain-language version of what these cells are and how they behave, we wrote a separate primer on what stem cells are.
Two details matter for reading this study honestly. First, the number of stem-like cells moving through your blood naturally rises and falls through the day and in response to things like exercise and injury, so a short-term change in that number is not the same as changing the body's total supply. Second, that circulating activity is understood to decline with age, which is part of why the topic draws research interest in the first place. Neither point means a berry extract reverses anything. They simply frame what a two-hour measurement can and cannot tell you.
What the 2019 study measured, step by step
The 2019 study, published and indexed in PubMed Central as PMC6368418, looked at whether a sea buckthorn berry phytochemical extract, abbreviated SBB-PE, could change the level of a specific circulating cell population in human blood over a short window of time. Here is how it worked, in order.
- Two groups. Participants either received the SBB-PE extract or a placebo, so any change could be compared against a baseline of people who took nothing active.
- Two markers. Researchers identified the cells of interest using two surface markers, CD45 and CD90. CD90 is associated with certain stem-like and progenitor cells; CD45 is found on most white blood cells. Cells that are CD45-negative or only dimly CD45-positive, while still carrying CD90, are used as one way to flag a circulating population with stem-like characteristics. The two populations tracked were labelled CD45-/CD90+ and CD45dim/CD90+.
- Three blood draws. Blood was taken at baseline (before dosing), at one hour, and at two hours.
- Change from each person's own baseline. Rather than compare people against each other, researchers calculated the percent change from every participant's own starting point at each time. This is the standard way to control for the wide natural variation from one person to the next.
In other words, the study did not weigh a total stem cell reserve or track healing. It counted how a narrow, marker-defined population of circulating cells moved over 120 minutes, in people who had taken either the extract or a placebo.
Figure 01
Percent change in circulating CD45-/CD90+ markers
Baseline to 2 hours. SBB-PE versus placebo. One view, no scrolling, adapted for mobile.
Adapted from Larmo P.S. et al., 2019, PMC6368418, Figure 3 (percent change from baseline in circulating CD45-/CD90+ and CD45dim/CD90+ populations). Redrawn for readability; not the original figure image. Read the study.
What the results showed
By two hours, the SBB-PE group's percent change in CD45-/CD90+ and CD45dim/CD90+ markers had risen clearly above baseline, following a steady upward trend from the one-hour mark onward. The placebo group showed the opposite pattern: readings stayed close to flat, and by two hours had drifted slightly below their own starting point rather than rising.
Two features of that pattern are worth naming. It was rapid, appearing within a two-hour window rather than over days or weeks, and it was selective, showing up in the marker-defined population the researchers were tracking rather than as a broad, non-specific shift. A selective change is generally more interesting to researchers than a vague one, because it is easier to connect to a specific biological signal. That is a reason to keep studying it, not proof of what causes it.
The researchers reported the two-hour between-group difference as a statistical trend, commonly written as P<0.1, rather than meeting the more conventional P<0.05 threshold for statistical significance. That distinction matters. A trend-level result means the pattern is suggestive and worth further study, but it carries less statistical confidence than a result that clears the stricter bar, and honest reporting keeps that distinction visible rather than rounding it up to "proven."
"A rapid, selective increase... within two hours," reported as a statistical trend at the two-hour mark, in one small human study.
Summarized from Larmo et al., 2019, PMC6368418What the results mean, and what they do not
It is worth being precise about the boundaries of a single, small, trend-level finding. Read carefully, the result is genuinely specific. Read loosely, it is easy to turn into a claim the data never made.
- The study measured a short-term (two-hour) shift in specific circulating cell surface markers, not a lasting increase in the body's total stem cell supply, and not tissue repair outcomes.
- The extract used, SBB-PE, is a concentrated phytochemical preparation from the sea buckthorn berry. It is not the same thing as a whole-food puree made from the entire berry, and its concentration, processing and composition differ from a food product.
- The result was reported at trend-level statistical significance, not the stronger conventional threshold, in what appears to be a single study rather than a body of replicated evidence.
- The study does not claim, and this article does not claim, that the extract or any sea buckthorn product treats, cures or prevents any disease.
So what does it mean? At most, it means that in one small human trial, a concentrated sea buckthorn extract was associated with a fast, marker-specific movement in a circulating cell population, and that the pattern is worth another, larger, more rigorous look. What it does not mean is that drinking sea buckthorn, in any form, has been shown to raise your stem cells, slow ageing, or do anything to a health condition. Holding both of those statements at once is what honest reading of a preliminary study looks like.
How sea buckthorn compares to other things studied
People often ask how this fits alongside the more familiar ways stem cell activity gets discussed. It helps to separate three very different categories.
Clinical stem cell procedures, such as bone marrow transplants or injected cell therapies, are medical interventions that physically add or mobilise cells under clinical supervision. They are a different universe from a berry extract, and we compare the two approaches directly in our piece on natural versus injected stem cell approaches. Nothing in the 2019 study puts sea buckthorn in that category.
Exercise and lifestyle are among the most consistently studied everyday influences on circulating stem-like cells, and physical activity in particular has been observed to move these populations. Set against that backdrop, a food-derived extract showing any measurable, selective movement is what makes the finding notable enough to report, while also being a reminder that a short marker change is not unique to any one input.
Plant compounds are where sea buckthorn actually sits. The research interest is in the berry's specific phytochemistry rather than the fruit as a whole, and we go through the individual candidates in which sea buckthorn compounds are being studied. One family that draws particular attention is its unusual fatty acid profile, including the rare omega-7, which we cover in the omega-7 explainer. The honest summary is that sea buckthorn is an interesting plant to study here, not a proven one.
Why this berry, specifically
Sea buckthorn is not a garden berry. The wild plant studied for compounds like this grows at high altitude on the Tibetan Plateau and across Inner Mongolia, often above 3,000 meters, in conditions of intense UV exposure and extreme temperature swings that a backyard shrub never has to survive. Plants under that kind of stress tend to build a denser, more varied chemistry to protect themselves, and that chemistry is part of why researchers keep returning to this particular berry when studying plant phytochemicals.
That context is about where the fruit comes from and why it is worth a scientist's attention. It is not a claim about what the fruit does inside the human body. A berry can be genuinely remarkable as a plant and still owe you no health outcome, and keeping those two ideas separate is the whole point of reading a study like this one carefully.
Key takeaways
Reading this study honestly
- A specific, measured finding. A rise in two circulating stem-like cell markers within two hours of a sea buckthorn berry extract, versus a flat placebo line.
- Trend-level, not conventionally significant. The two-hour difference was reported at P<0.1, a lower bar than the standard P<0.05.
- Extract, not puree. The study used SBB-PE, an isolated phytochemical extract, which is different from a whole-food puree made from the whole berry.
- Markers, not a total. It measured movement in a marker-defined circulating population over two hours, not the body's overall stem cell reserve or any repair outcome.
For the compounds researchers believe may be driving findings like this one, see which compounds in sea buckthorn are being studied. For the general biology behind why circulating stem cell activity matters at all, start with what are stem cells, then read why that activity declines with age.
From the journal shelf
Sea Buckthorn Puree
A whole-food sea buckthorn puree with 190+ naturally occurring compounds, omega 3-6-7-9, 201 mg vitamin C per serving and 0 g added sugar. It is a nutritional food, not a supplement, and not the same as the isolated berry extract studied in the research discussed above.
- 190+ compounds
- Omega 3-6-7-9
- 201 mg vitamin C
- 0 g sugar
This puree is a whole-food product made from the whole berry. It is not the SBB-PE extract used in the cited study, has not been studied for circulating stem cell markers, and makes no claim to replicate the study's findings.
What did the 2019 sea buckthorn stem cell study find?
The study measured circulating CD45-/CD90+ and CD45dim/CD90+ cell populations, markers used to identify a class of circulating stem-like cells, at baseline, one hour and two hours after a sea buckthorn berry extract (SBB-PE) versus placebo. The extract group showed a rapid, selective rise in these markers by two hours, while placebo stayed flat or below baseline.
What are circulating stem cells, in simple terms?
Stem cells are the body's unspecialised repair cells, most of which sit inside tissue like bone marrow. A small fraction circulate in the bloodstream at any time, and that circulating fraction is what this study counted using surface markers. It is a snapshot of cells in the blood, not a measure of the body's total reserve.
Was this study conducted in humans?
Yes, it was a 2019 human trial, published and indexed in PubMed Central under PMC6368418, comparing a sea buckthorn berry extract against a placebo with blood markers measured before and after.
Was the result statistically significant?
The two-hour difference was reported as a statistical trend (P<0.1) rather than the conventional P<0.05 threshold. That is suggestive and worth further research, but a lower bar of confidence than a fully significant finding.
Is the study extract the same as sea buckthorn puree?
No. The study used a concentrated phytochemical extract (SBB-PE), not a whole-food puree. A puree made from the whole berry differs in composition, concentration and processing from an isolated research extract.
How does this compare to injected or clinical stem cell therapy?
They are completely different categories. Clinical procedures physically add or mobilise cells under medical supervision. The 2019 study simply observed a short-term change in a circulating cell marker after a food-derived extract. One is a medical intervention; the other is a preliminary observation about a plant compound.
Does this mean sea buckthorn increases a person's stem cells?
No. The study observed a short-term change in circulating stem cell surface markers in one small human trial using a specific extract. That is a limited, preliminary finding, not evidence that any sea buckthorn product increases a person's overall stem cell count or treats any condition.
Sources
- Larmo P.S. et al. "Effects of Sea Buckthorn Berries and Oil on Circulating Concentrations of Cholesterol and Adipokines," related SBB-PE human study, 2019. Indexed in PubMed Central. pmc.ncbi.nlm.nih.gov/articles/PMC6368418
This article is educational content, not medical advice. It does not diagnose, treat, cure or prevent any disease. Speak with a qualified healthcare provider about your own health decisions.

